Verisk Health Launches New Tool for Analyzing the Impact of Lifestyle Behaviors on Healthcare Costs and Utilization

WALTHAM, Mass., March 11, 2009 — Verisk Health, Inc., a global leader in healthcare data analytics and risk management, today announced several upgrades to its Explorer product line, including functionality that allows users to evaluate the impact of a member’s lifestyle behaviors on an organization’s overall healthcare and utilization costs. Explorer is one of several tools from Verisk Health that focuses on identifying, understanding, and taking action to improve an organization’s exposure to healthcare risk. Specifically, Explorer is a suite of risk adjustment and predictive modeling solutions that enable organizations to analyze, predict, manage, and minimize healthcare risks and costs associated with Commercial, Medicare, and Medicaid populations.

“It’s widely known that if you smoke, suffer from depression, or are overweight, there is an impact on your health. The latest release of Explorer shows how such lifestyle behaviors actually impact cost,” said Nathan Gunn, MD, chief medical officer of Verisk Health. “From there, we can identify at a population level, the individuals who will most benefit from clinical intervention programs and make wellness and disease management programs more effective.”

Verisk Health’s Explorer is a web-native, application service provider (ASP) solution that enables healthcare organizations to leverage data to better manage their risk. Two new features available in this latest release include:

  • HRA Impact Report. The HRA Impact Report provides the impact of lifestyle behaviors on cost and utilization. For example, a customer can see the effect smoking has on their overall claim costs and utilization of services such as ER visits. This information is a critical data point for helping customers fine tune and measure the impact of behavior modification programs.
  • Medical Intelligence Report. The updated Medical Intelligence report features several new clinical sections, including a clinical disease fingerprint that reveals the relationship between the risk index and the care gap index. It then compares this to the norm and identifies where to focus to improve quality. It also displays areas of clinical quality performance and economic opportunity by identifying individuals who would benefit from case management, disease management, or wellness programs. The new report is an actionable roadmap that can help customers design and implement the most effective programs for their care community.

Please join us for a complimentary webinar on March 17th at 1 pm to learn more about Explorer and these latest enhancements. Registration is required. Please click here.

Verisk Health is an industry leader in the area of risk identification and data analytics with a comprehensive suite of products, including:

  • enterprise business intelligence solutions
  • risk adjustment and predictive modeling
  • HEDIS quality and reporting solutions
  • data aggregation, analytics, and benchmarking solutions
  • clinical, analytics, and technology consulting services

About Verisk Health
Verisk Health, a subsidiary of Verisk Analytics, leverages healthcare data to help businesses and governments understand their medical and financial risk for the purpose of managing costs and clinical outcomes more effectively. Through the combination of leading predictive science, the finest evidence-based clinical engine, and superior technology, we have created the most extensive independent risk assessment and decision analytics platform in the healthcare industry. Our primary focus is to identify actionable strategies for managing healthcare costs and quality at both the individual and population levels. We consistently research, evaluate, and invest in our business to ensure that we remain leaders in our industry and the most efficient and effective solution for our clients. For more information, please visit

Release: Immediate

Trish Tarantino (Verisk Health)

Archived Press